Raphael Deferiere serves as Chief Accounting Officer at Centessa Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Raphael Deferiere has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 2, 2026 involved receiving (via award) 42,000 shares valued at $0.
Raphael Deferiere currently holds 42,000 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $0. This represents their equity stake as Chief Accounting Officer.
Based on SEC Form 4 filings, Raphael Deferiere has been a net neutral trader of CNTA stock. They have purchased $0 and sold $0 worth of shares.
Raphael Deferiere's most recent insider trade was on Feb 2, 2026, when they sold 42,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |